Netherlands· NL-4870add06519

Mebeverine HCl Aurobindo Retard 200 mg, harde capsules met gereguleerde afgifte

A mebeverine product containing mebeverinehydrochloride, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC A03AA04

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about mebeverinehydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Mebeverine is registered in 13 of 19 countries.

Countries holding a registration under ATC A03AA04 (mebeverine), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
8 of them publish a price we can compare per daily dose

Search mebeverine products by name

Mebeverine · ATC A03AA04

13 / 19 countries

Belgiumprice
Czechiaprice
Denmark
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Spainprice
Switzerlandprice
United Kingdom

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of mebeverine costs, country by country.

Normalised to the WHO defined daily dose (0.4 g), the median price runs from $0.20 in France to $1.31 in Switzerland — a ×6.5 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Mebeverine · price per daily dose (0.4 g)

USD · FX 28 Sept 2026

CH Switzerland$1.31
FR France$0.20

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: MEBEVERINEHYDROCHLORIDE
Manufacturer: Aurobindo Pharma B.V.
Country: Netherlands (NL)
ATC code: A03AA04
ATC class: Mebeverine
Defined daily dose: 0.4 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
119122

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Mebeverine in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All mebeverine products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Colofac, Colofac Retard
Belgium · Duspatalin, Duspatalin Retard
Bulgaria · Дуспаверин, Дуспаталин
Cyprus · Medoverine, Spasverin
Czechia · Duspatalin Retard
Germany · Duspatal, Duspatal Retard
Denmark · Duspatalin Retard
Estonia · Mebeverine Sanoswiss
Spain · Duspatalin, Mebeverina Tarbis
France · Duspatalin, Mebeverine Zentiva
United Kingdom (Northern Ireland) · Aurobeverine Mr, Boots Ibs Symptom Relief
Greece · Duspatalin
Croatia · Colospa Retard, Rudakol
Ireland · Colofac, Mebeverine Hydrochloride Azure Pharmaceuticals
Iceland · Duspatalin Retard
Italy · Duspatal
Lithuania · Duspatalin, Mebeverine Sanoswiss
Luxembourg · Duspatalin, Duspatalin Retard
Latvia · Duspatalin, Mebeverine Sanoswiss
Malta · Colofac Retard, Mebeverine Hydrochloride Aspire Pharma (Malta)
Poland · Auroverin Mr, Duspatalin Gastro
Portugal · Duspatal Retard, Mebeverina Aristo
Romania · Colospasmin, Duspatalin
Slovenia · Rudakol
Slovakia · Duspatalin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/10b7a14d-b667-45cc-9caf-f51ce26b57c4
GET /v1/drugs/10b7a14d-b667-45cc-9caf-f51ce26b57c4?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule met gereguleerde afgifte, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h119122_smpc.pdf",
  "strength": null,
  "atc_label": "Mebeverine",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg119122",
  "excipients": [
    "ETHYLCELLULOSE (E 462)",
    "GELATINE (E 441)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "MACROGOL 6000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MAÏSZETMEEL",
    "POVIDON K 30 (E 1201)",
    "SACCHAROSE",
    "SUIKERZETMEELBOLLETJES",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "MEBEVERINEHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h119122.pdf",
  "authorised_at": "2017/05/31",
  "procedure_number": "NL/H/3750/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "119122",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about mebeverine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console